Dr Aileen Fernandez (@aileenilianaphd) 's Twitter Profile
Dr Aileen Fernandez

@aileenilianaphd

Liquid Product Specialist | Translational cancer researcher | #LatinaInSTEM #afroLatina #Blackincancer 🇩🇴 *Tweets are my own*

ID: 1193988927738306560

calendar_today11-11-2019 20:28:45

5,5K Tweet

1,1K Followers

1,1K Following

Dr Sarah Sammons (@drsarahsam) 's Twitter Profile Photo

Donald is the brightest researcher I know in studying the estrogen receptor in breast cancer. His work has led to one approved and several in development novel therapies for breast cancer. He is fearful. Listen to him. apnews.com/article/trump-…

TLC Conference (@tlcconference) 's Twitter Profile Photo

Keeping order in the courtroom, our co-chairs Drs. Tina Cascone and Stephen V Liu, MD will serve as the “bailiffs” for The Trial of the Century at this 2-day CE-accredited conference. Will the "defense" make a compelling case, or will objections be sustained? Join us April 10-12 at

Keeping order in the courtroom, our co-chairs Drs. Tina Cascone and <a href="/StephenVLiu/">Stephen V Liu, MD</a> will serve as the “bailiffs” for The Trial of the Century at this 2-day CE-accredited conference. Will the "defense" make a compelling case, or will objections be sustained? Join us April 10-12 at
Cancer Research Institute (@cancerresearch) 's Twitter Profile Photo

Cancer research cannot wait! In response to NIH uncertainty & funding cuts, we’re committing $2.5M to support 10 additional postdoctoral fellowships over the next year at leading universities and research centers worldwide. Details: bit.ly/4iEQNsJ #CancerResearch

Cancer research cannot wait! In response to <a href="/NIH/">NIH</a> uncertainty &amp; funding cuts, we’re committing $2.5M to support 10 additional postdoctoral fellowships over the next year at leading universities and research centers worldwide. Details: bit.ly/4iEQNsJ #CancerResearch
Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo

Evolution of HER2 testing over 40 yrs. IHC lacks the dynamic range to predict outcomes with T-DXd, yet novel quantitative assays are emerging. We presented data with HS-HER2 to predict T-DXd activity at #ESMO24. More data coming at #ASCO25. Stay tuned. nature.com/articles/s4157…

Evolution of HER2 testing over 40 yrs.

IHC lacks the dynamic range to predict outcomes with T-DXd, yet novel quantitative assays are emerging.

We presented data with HS-HER2 to predict T-DXd activity at #ESMO24. More data coming at #ASCO25.

Stay tuned.

nature.com/articles/s4157…
Adriana Kahn, MD (@adrianakahnmd) 's Twitter Profile Photo

“When research funding is cut, #patients pay the price and a generation of discoveries is lost. We must protect the independence and integrity of science and remain focused on the #patients. This is not someone else’s problem, but ours” by AACR President Patricia M. LoRusso AACR #AACR25 Yale Cancer Center

“When research funding is cut, #patients pay the price and a generation of discoveries is lost. We must protect the independence and integrity of science and remain focused on the #patients. This is not someone else’s problem, but ours” by <a href="/AACRPres/">AACR President Patricia M. LoRusso</a> <a href="/AACR/">AACR</a> #AACR25 <a href="/YaleCancer/">Yale Cancer Center</a>
Infinite Strength (@infinitembc) 's Twitter Profile Photo

What a magical night! We raised over $100,000 for single mothers living with MBC! Thank you Ocean House for providing this beautiful venue. And a special thank you to our sponsors, donors & the incredible oncologists who made the event so successful!

Christine Hodgdon (@christeeny513) 's Twitter Profile Photo

In 2022, Janice Cowden , Dear Dr. Researcher, PhD, & I sat together to hear the much anticipated DESTINY-Breast 04 trial results. As cancer survivors, when we see data, we see the patients behind the data, we ARE the patients behind the data, & we’re grateful to still be here! #ASCO25

In 2022, <a href="/JaniceTNBCmets/">Janice Cowden</a> , <a href="/corrie_painter/">Dear Dr. Researcher, PhD</a>, &amp; I sat together to hear the much anticipated DESTINY-Breast 04 trial results. As cancer survivors, when we see data, we see the patients behind the data, we ARE the patients behind the data, &amp; we’re grateful to still be here!  #ASCO25
Dr Sarah Sammons (@drsarahsam) 's Twitter Profile Photo

First-line Sacituzumab + Pembrolizumab improves PFS in 1st Line TNBC. 🚨🔔‼️ Crossover 80% Sacituzumab Offered! Very few patients with prior IO, few who relapsed within 6-12 months. OS looks similar but early days. #bcsm great job Sara Tolaney !!

First-line Sacituzumab + Pembrolizumab improves PFS in 1st Line TNBC. 🚨🔔‼️

Crossover 80% Sacituzumab Offered! 

Very few patients with prior IO, few who relapsed within 6-12 months. 

OS looks similar but early days. 

#bcsm great job <a href="/stolaney1/">Sara Tolaney</a> !!
Vivek Subbiah, MD (@viveksubbiah) 's Twitter Profile Photo

🚨 Wow! #ASCO25 ASCO was absolutely massive! 10 NEJM papers published simultaneously 👉 all practice-changing studies ! 🔬✨🧵 See below for these studies 👇@oncoalert

GRASP (@grasptweets) 's Twitter Profile Photo

We've all heard about the association between alcohol intake and quality of life in breast cancer survivors, but what does that actually mean? Join us on Thursday, June 12 as we dig deeper into the topic and discuss Poster #11114. graspcancer.org/events/asco25-… #bcsm #registertoday

We've all heard about the association between alcohol intake and quality of life in breast cancer survivors, but what does that actually mean? Join us on Thursday, June 12 as we dig deeper into the topic and discuss Poster #11114.
graspcancer.org/events/asco25-…
#bcsm #registertoday